ArticleInternational ophthalmology2025
The NYEE-Orbis oculoplastic surgery online curriculum: global access to oculoplastics education.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research on the application of computer-assisted surgical technology in ophthalmic plastic surgery education.BMC medical education · 2025Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study investigates the global reach of two novel, interactive, online, and free courses entitled "Basics of Oculoplastic Surgery" (BOS) and "Intermediate Oculoplastic Surgery" (IOS) and assesses how effectively they enhanced knowledge of oculoplastics conditions and procedures.
methodsThe two courses were developed and uploaded online via the e-learning platform of Orbis International, Cybersight. Pre- and post-course surveys were administered to all enrollees to assess for demographics, course progress, baseline experience, and learning outcomes. Pre- and post-course survey data were compared using chi-square tests for yes or no questions and student t-tests for Likert scale items for each course separately.
resultsAs of August 2024, the BOS course had 2776 enrollees from 150 countries, while the IOS course had 1722 enrollees from 139 countries. The most frequent users of both courses were ophthalmologists, residents, medical students, nurses, and optometrists. For the BOS and IOS courses, 518 (18.7%) and 188 (10.9%) enrollees completed the courses, respectively. Pre- and post-course survey participants reported significant improvements in understanding oculoplastic procedures and conditions in the two courses (p < 0.0001 for all). Qualitative feedback for the BOS and IOS were overwhelmingly positive (95.2% and 96.9%, respectively).
conclusionBoth the BOS and IOS courses effectively reached a global audience and improved self-reported comfort and knowledge in oculoplastic procedures and conditions. These courses demonstrate promise as accessible and useful oculoplastic surgery education tools to international audiences of various backgrounds.
Indexed as
Identifiers
40425953What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.